Toggle Mobile Navigation

Archive for the ‘Drug Safety’ Category

Considering the Patient’s Point of View When Explaining Medication Side Effects and More

Starting or changing medication can be stressful for patients, especially if there is a communication barrier between them and their physician. While doctors, nurses, pharmacists and other professionals in the fields of medicine understand side effects and reactions that come with certain medications, a patient most likely does not. Taking their point of view into consideration is paramount for patient-centric care and successful treatments.

According to a recent article published by the BBC, people usually have negative responses to medical information pamphlets and the like. A new report states that patients find this form of communicating side…

READ MORE


FDA Head & Former ExL Speaker, Dr. Scott Gottlieb, Takes to Twitter With Clear Stance on Vaccines

Recently sworn-in commissioner of the Food and Drug Administration (FDA) Dr. Scott Gottlieb has affirmed his stance on the vaccination debate in many instances, but a recent Twitter post is sure to make his intentions on the matter perfectly clear. Unlike the man who appointed him to his position, President Donald Trump, toes the line of anti-vaccine and pro-vaccine, Gottlieb is embracing his new status to spread scientific data and other newsworthy tidbits on the matter.

In a message to his followers, Dr. Gottlieb shared an infographic the country before and…

READ MORE


Senate Confirms New Head of FDA: Two-Time ExL Speaker Dr. Scott Gottlieb

ExL Events would like to congratulate our speaker alumnus Dr. Scott Gottlieb for the recent United States Senate confirmation, naming him the new Food and Drug Administration commissioner. Dr. Gottlieb was the keynote speaker at ExL’s 2nd Trial Design Innovation Conference and was also a featured speaker at our Private Fee-for-Service event.

President Donald Trump nominated Gottlieb earlier this year, for his previous service as deputy commissioner for the FDA, as well as his experience in the pharmaceutical and health care industries. As the FDA’s newly appointed commissioner, Gottlieb will…

READ MORE


Key Stakeholders Gather This Fall to Discuss Abuse-Deterrent Formulations, Regulations and Policies

Dan Cohen, Chair, ABUSE DETERRENT COALITION
Dan Cohen, Forum Chair, Abuse Deterrent Coalition

This guest blog post is written by Dan Cohen, the Forum Chair of the Abuse Deterrent Coalition and speaker at the 3rd Human Abuse Liability & Abuse-Deterrent Formulations conference, which takes place in Arlington, VA this November 2-3. 

The prominence of Abuse Deterrent Formulations (ADF) in the public policy debate has never been greater.  This fall is no exception as we are now at yet another critical juncture for the ADF sector, with…

READ MORE


live chat software